Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/1024   
Active ingredient: Metreleptin
Indication: Treatment of Lawrence syndrome
Sponsor: Aegerion Pharmaceuticals B.V.
Atrium Building, 8th Floor, Strawinskylaan 3127, 1077 ZX Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2012 Orphan designation EMA/OD/035/12 (2012)5147 of 17/07/2012
17/02/2014 Transfer of orphan designation EMA/OD/035/12/T/01 (2014)1084 of 13/02/2014
17/04/2014 Transfer of orphan designation EMA/OD/035/12/T/02 (2014)2706 of 15/04/2014
17/06/2014 Change of name and/or address of sponsor
27/03/2015 Transfer of orphan designation EMA/OD/035/12/T/03 (2015)2215 of 25/03/2015
04/12/2017 Transfer of orphan designation EMA/OD/035/12/T/04 (2017)8246 of 30/11/2017